vs
Side-by-side financial comparison of CPI Card Group Inc. (PMTS) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $153.1M, roughly 1.1× CPI Card Group Inc.). CPI Card Group Inc. runs the higher net margin — 4.8% vs -82.0%, a 86.8% gap on every dollar of revenue. On growth, CPI Card Group Inc. posted the faster year-over-year revenue change (22.3% vs -22.7%). CPI Card Group Inc. produced more free cash flow last quarter ($35.2M vs $-36.6M). Over the past eight quarters, CPI Card Group Inc.'s revenue compounded faster (16.9% CAGR vs -11.5%).
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PMTS vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $153.1M | $164.7M |
| Net Profit | $7.3M | $-135.0M |
| Gross Margin | 31.5% | — |
| Operating Margin | 12.0% | -43.3% |
| Net Margin | 4.8% | -82.0% |
| Revenue YoY | 22.3% | -22.7% |
| Net Profit YoY | 8.5% | -104.8% |
| EPS (diluted) | $0.62 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $153.1M | $164.7M | ||
| Q3 25 | $138.0M | $211.0M | ||
| Q2 25 | $129.8M | $178.9M | ||
| Q1 25 | $122.8M | $1.2B | ||
| Q4 24 | $125.1M | $213.2M | ||
| Q3 24 | $124.8M | $196.8M | ||
| Q2 24 | $118.8M | $186.7M | ||
| Q1 24 | $111.9M | $210.1M |
| Q4 25 | $7.3M | $-135.0M | ||
| Q3 25 | $2.3M | $15.9M | ||
| Q2 25 | $518.0K | $-64.8M | ||
| Q1 25 | $4.8M | $866.6M | ||
| Q4 24 | $6.8M | $-65.9M | ||
| Q3 24 | $1.3M | $-106.7M | ||
| Q2 24 | $6.0M | $-99.2M | ||
| Q1 24 | $5.5M | $-91.6M |
| Q4 25 | 31.5% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 30.9% | — | ||
| Q1 25 | 33.2% | — | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 35.8% | — | ||
| Q2 24 | 35.7% | — | ||
| Q1 24 | 37.1% | — |
| Q4 25 | 12.0% | -43.3% | ||
| Q3 25 | 9.4% | 1.4% | ||
| Q2 25 | 7.3% | -19.5% | ||
| Q1 25 | 11.5% | 82.5% | ||
| Q4 24 | 12.7% | -76.2% | ||
| Q3 24 | 14.3% | -27.7% | ||
| Q2 24 | 12.5% | -21.5% | ||
| Q1 24 | 12.6% | -21.6% |
| Q4 25 | 4.8% | -82.0% | ||
| Q3 25 | 1.7% | 7.5% | ||
| Q2 25 | 0.4% | -36.3% | ||
| Q1 25 | 3.9% | 73.7% | ||
| Q4 24 | 5.4% | -30.9% | ||
| Q3 24 | 1.0% | -54.2% | ||
| Q2 24 | 5.1% | -53.1% | ||
| Q1 24 | 4.9% | -43.6% |
| Q4 25 | $0.62 | $-1.63 | ||
| Q3 25 | $0.19 | $0.20 | ||
| Q2 25 | $0.04 | $-0.83 | ||
| Q1 25 | $0.40 | $10.04 | ||
| Q4 24 | $0.56 | $-0.85 | ||
| Q3 24 | $0.11 | $-1.39 | ||
| Q2 24 | $0.51 | $-1.29 | ||
| Q1 24 | $0.46 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.7M | $1.9B |
| Total DebtLower is stronger | $286.7M | — |
| Stockholders' EquityBook value | $-17.3M | $-205.3M |
| Total Assets | $403.2M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.7M | $1.9B | ||
| Q3 25 | $16.0M | $1.7B | ||
| Q2 25 | $17.1M | $2.0B | ||
| Q1 25 | $31.5M | $2.0B | ||
| Q4 24 | $33.5M | $1.1B | ||
| Q3 24 | $14.7M | $1.0B | ||
| Q2 24 | $7.5M | $1.1B | ||
| Q1 24 | $17.1M | $884.8M |
| Q4 25 | $286.7M | — | ||
| Q3 25 | $308.4M | — | ||
| Q2 25 | $310.9M | — | ||
| Q1 25 | $280.7M | — | ||
| Q4 24 | $280.4M | — | ||
| Q3 24 | $280.2M | — | ||
| Q2 24 | $269.7M | — | ||
| Q1 24 | $265.3M | — |
| Q4 25 | $-17.3M | $-205.3M | ||
| Q3 25 | $-25.7M | $-155.8M | ||
| Q2 25 | $-29.0M | $-206.5M | ||
| Q1 25 | $-29.7M | $-185.8M | ||
| Q4 24 | $-35.6M | $-1.1B | ||
| Q3 24 | $-42.8M | $-1.1B | ||
| Q2 24 | $-44.6M | $-980.2M | ||
| Q1 24 | $-48.5M | $-893.9M |
| Q4 25 | $403.2M | $2.9B | ||
| Q3 25 | $407.1M | $2.6B | ||
| Q2 25 | $399.8M | $2.6B | ||
| Q1 25 | $351.9M | $2.7B | ||
| Q4 24 | $349.7M | $1.7B | ||
| Q3 24 | $342.3M | $1.8B | ||
| Q2 24 | $321.4M | $1.9B | ||
| Q1 24 | $319.8M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $39.6M | $-34.3M |
| Free Cash FlowOCF − Capex | $35.2M | $-36.6M |
| FCF MarginFCF / Revenue | 23.0% | -22.3% |
| Capex IntensityCapex / Revenue | 2.9% | 1.4% |
| Cash ConversionOCF / Net Profit | 5.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.3M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $39.6M | $-34.3M | ||
| Q3 25 | $10.0M | $-66.3M | ||
| Q2 25 | $4.3M | $-58.3M | ||
| Q1 25 | $5.6M | $870.1M | ||
| Q4 24 | $26.7M | $-30.0M | ||
| Q3 24 | $12.5M | $-77.0M | ||
| Q2 24 | $-4.8M | $-71.5M | ||
| Q1 24 | $8.9M | $70.8M |
| Q4 25 | $35.2M | $-36.6M | ||
| Q3 25 | $5.3M | $-69.7M | ||
| Q2 25 | $533.0K | $-59.6M | ||
| Q1 25 | $292.0K | $868.4M | ||
| Q4 24 | $21.6M | $-33.8M | ||
| Q3 24 | $11.1M | $-77.5M | ||
| Q2 24 | $-6.0M | $-78.8M | ||
| Q1 24 | $7.4M | $61.2M |
| Q4 25 | 23.0% | -22.3% | ||
| Q3 25 | 3.8% | -33.1% | ||
| Q2 25 | 0.4% | -33.3% | ||
| Q1 25 | 0.2% | 73.8% | ||
| Q4 24 | 17.3% | -15.8% | ||
| Q3 24 | 8.9% | -39.4% | ||
| Q2 24 | -5.0% | -42.2% | ||
| Q1 24 | 6.6% | 29.1% |
| Q4 25 | 2.9% | 1.4% | ||
| Q3 25 | 3.4% | 1.6% | ||
| Q2 25 | 2.9% | 0.7% | ||
| Q1 25 | 4.3% | 0.1% | ||
| Q4 24 | 4.0% | 1.8% | ||
| Q3 24 | 1.2% | 0.3% | ||
| Q2 24 | 1.0% | 4.0% | ||
| Q1 24 | 1.3% | 4.6% |
| Q4 25 | 5.39× | — | ||
| Q3 25 | 4.32× | -4.17× | ||
| Q2 25 | 8.39× | — | ||
| Q1 25 | 1.17× | 1.00× | ||
| Q4 24 | 3.94× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | -0.79× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
PTCT
Segment breakdown not available.
